Early Integration of Palliative Care in Esophageal Cancer Patients
NCT02547142 · Status: TERMINATED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 12
Last updated 2019-03-14
Summary
Palliative care physicians and nurses are trained to help reduce suffering and improve quality of life in patients under their care. Their services also include other components such as referral to dietitians, social workers and community resources, to assist patients in their homes. In addition to this, they may also administer interventions to make patients more comfortable, assisting them and their families in making important decisions and providing support, during that time.
At present, palliative care is provided to esophageal cancer patients on an as-needed basis, through the referral of a heath care professional or the patient's request. This study aims to assess the impact of the integration of early palliative care combined with appropriate medical care in the metastatic esophageal cancer population, so that patients can benefit from these services at an earlier stage. It is hoped that this will improve quality of life, symptom management, depression and anxiety, as well as survival.
Conditions
- Esophageal Cancer
Interventions
- OTHER
-
Early Palliative Care
Metastatic esophageal cancer patients that receive early palliative care along with standard oncological care
Sponsors & Collaborators
-
St. Joseph's Healthcare Hamilton
collaborator OTHER - lead OTHER
Principal Investigators
-
Christian Finley, MD MPH FRCSC · McMaster University
Study Design
- Allocation
- NA
- Purpose
- SUPPORTIVE_CARE
- Masking
- NONE
- Model
- SINGLE_GROUP
Eligibility
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2016-01-18
- Primary Completion
- 2019-03-31
- Completion
- 2019-03-31
Countries
- Canada
Study Locations
More Related Trials
-
Quality of Life and Dysphagia Following Palliative Stenting in Esophageal Cancer
NCT01471249 ·Status: TERMINATED
-
Preoperative Chemotherapy vs. Chemoradiation in Esophageal / GEJ Adenocarcinoma
NCT01404156 ·Status: COMPLETED ·Phase: PHASE2/PHASE3
-
Focal Cryoballoon Ablation for Malignant Dysphagia
NCT06618742 ·Status: RECRUITING ·Phase: NA
-
Twice Weekly TP-HDFL for Recurrent or Metastatic Esophageal Cancer
NCT00154700 ·Status: COMPLETED ·Phase: PHASE2
-
Pre-operative Chemo (CPT11, Cisplatin), Radiotherapy, Plus Surgery for Resectable Esophageal Cancer
NCT00160875 ·Status: COMPLETED ·Phase: PHASE2/PHASE3
-
Definitive Concurrent Chemoradiotherapy With Docetaxel Plus Cisplatin Versus 5-fluorouracil Plus Cisplatin in Patients With Esophageal Squamous Cell Carcinoma
NCT02969473 ·Status: UNKNOWN ·Phase: PHASE2
-
Patient-Reported Symptom Care Versus Usual Care After Esophageal Cancer Surgery: A Single-Center Phase 3 Randomized Trial
NCT07211009 ·Status: NOT_YET_RECRUITING ·Phase: PHASE3
-
Palliative Radiotherapy and Brachytherapy for Oesophageal Cancer Dysphagia
NCT00665197 ·Status: COMPLETED ·Phase: PHASE3
-
Palliation Dysphagia Cancer Oesophagus Stent+Brachytherapy Versus Brachytherapy Only
NCT00653107 ·Status: TERMINATED ·Phase: PHASE3
-
Induction Chemotherapy for Locally Advanced Esophageal Cancer
NCT03110926 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE2
-
PG2 Concurrent With Chemoradiation for Locally Advanced Esophageal Cancer
NCT03611712 ·Status: COMPLETED ·Phase: PHASE2
-
A Nutritional Management Algorithm in Older Patients With Locally Advanced Esophageal Cancer
NCT02027948 ·Status: COMPLETED ·Phase: NA
-
Salvage Chemoradiation Therapy for Recurrence After Radical Surgery or Palliative Surgery in Esophageal Cancer Patients
NCT03731442 ·Status: RECRUITING ·Phase: PHASE3
-
Combination Chemotherapy Plus Radiation Therapy in Treating Patients With Cancer of the Esophagus
NCT00002631 ·Status: COMPLETED ·Phase: PHASE3
-
Quality Of Life Outcomes Following Treatment for Esophageal Cancer
NCT00598117 ·Status: COMPLETED
-
Oxaliplatin, Capecitabine, and Radiation Therapy in Patients Undergoing Surgery for Stage II, III, IV Esophageal Cancer
NCT00470184 ·Status: COMPLETED ·Phase: PHASE2
-
Nutritional Support During Induction Therapy for Esophageal Cancer
NCT05314946 ·Status: RECRUITING ·Phase: NA
-
Radiation Dose Intensification With Accelerated Hypofractionated Intensity Modulated Radiation Therapy and Concurrent Carboplatin and Paclitaxel for Inoperable Esophageal Cancer
NCT04046575 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE1
-
Serplulimab Combined With Chemotherapy in Patients With Resectable Esophageal Squamous Cell Carcinoma
NCT05659251 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE2
-
Impact of Cancer Therapy on Myocardial Function in Patients With Esophagus Cancer
NCT03619317 ·Status: UNKNOWN
-
Molecularly Tailored Therapy for Patients With Metastatic Cancer of the Esophagus and Stomach
NCT02358863 ·Status: TERMINATED ·Phase: NA
-
Endoscopic Therapy of Early Cancer in Barretts Esophagus
NCT00217087 ·Status: COMPLETED ·Phase: PHASE2
-
Oxaliplatin, Fluorouracil, Erlotinib Hydrochloride, and Radiation Therapy Before Surgery and Erlotinib Hydrochloride After Surgery in Treating Patients With Locally Advanced Cancer of the Esophagus or Gastroesophageal Junction
NCT01561014 ·Status: COMPLETED ·Phase: PHASE1
-
Quality of Life Outcomes Following Minimally Invasive and Open Esophagectomy for Esophageal Cancer
NCT01558648 ·Status: COMPLETED
-
Combination Chemotherapy Plus Radiation Therapy in Treating Patients With Esophageal Cancer
NCT00021320 ·Status: COMPLETED ·Phase: PHASE2